PART I
FINANCIAL INFORMATION
ITEM 1.
FINANCIAL STATEMENTS.
Nextera Enterprises, Inc.
Condensed Consolidated Balance
Sheets
(Amounts in thousands, except share amounts)
|
|
September 30, 2007
|
|
December 31,
2006
|
|
|
|
(Unaudited)
|
|
|
|
Assets
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
412
|
|
$
|
597
|
|
Accounts
receivable, net of allowances for customer deductions and doubtful accounts
of $4,100 at September 30, 2007
|
|
741
|
|
|
|
Inventories
|
|
1,983
|
|
2,595
|
|
Due from
supplier
|
|
|
|
127
|
|
Prepaid expenses
and other current assets
|
|
328
|
|
260
|
|
Total current
assets
|
|
3,464
|
|
3,579
|
|
|
|
|
|
|
|
Property and
equipment, net
|
|
256
|
|
284
|
|
Goodwill
|
|
8,969
|
|
10,969
|
|
Intangible
assets, net
|
|
12,377
|
|
12,827
|
|
Other assets
|
|
461
|
|
484
|
|
Total assets
|
|
$
|
25,527
|
|
$
|
28,143
|
|
|
|
|
|
|
|
Liabilities
and Stockholders Equity
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
Accounts payable
and accrued expenses
|
|
$
|
1,876
|
|
$
|
4,364
|
|
Revolver credit
facility
|
|
2,750
|
|
|
|
Current portion
of long-term debt
|
|
750
|
|
|
|
Total current
liabilities
|
|
5,376
|
|
4,364
|
|
|
|
|
|
|
|
Long-term debt,
net of current portion
|
|
8,750
|
|
11,718
|
|
|
|
|
|
|
|
Deferred taxes
|
|
416
|
|
236
|
|
Other long-term
liabilities
|
|
934
|
|
1,334
|
|
Commitments and
contingencies
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable
Preferred Stock, $0.001 par value. Liquidation preference of $100 per share:
|
|
|
|
|
|
Series B
Cumulative Non-Convertible, 200,000 authorized shares designated, 25,801 and
0 issued and outstanding at September 30, 2007 and December 31, 2006,
respectively.
|
|
1,869
|
|
|
|
Series C
Cumulative Non-Convertible, 200,000 authorized shares designated, none
outstanding at September 30, 2007 and December 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders
equity:
|
|
|
|
|
|
Preferred Stock,
$0.001 par value, 10,000,000 shares authorized. Liquidation preference of
$100 per share:
|
|
|
|
|
|
Series A
Cumulative Convertible, 600,000 authorized shares designated, 55,398 and
52,429 issued and outstanding at September 30, 2007 and December 31, 2006,
respectively.
|
|
5,540
|
|
5,243
|
|
Class A Common
Stock, $0.001 par value, 95,000,000 shares authorized, 38,692,851 and
38,492,851 shares issued and outstanding at September 30, 2007 and December
31, 2006, respectively.
|
|
39
|
|
38
|
|
Class B Common
Stock, $0.001 par value, 4,300,000 shares authorized, 3,844,200 shares issued
and outstanding at September 30, 2007 and December 31, 2006, respectively.
|
|
4
|
|
4
|
|
Additional
paid-in capital
|
|
165,711
|
|
165,218
|
|
Accumulated
deficit
|
|
(163,112
|
)
|
(160,012
|
)
|
Total
stockholders equity
|
|
8,182
|
|
10,491
|
|
Total
liabilities and stockholders equity
|
|
$
|
25,527
|
|
$
|
28,143
|
|
See
Notes to Condensed Consolidated Financial Statements
3
Nextera Enterprises, Inc.
Condensed Consolidated Statements
of Operations
(Amounts in thousands, except share amounts;
unaudited)
|
|
Three Months Ended
September 30,
|
|
Nine Months Ended
September 30,
|
|
|
|
2007
|
|
2006
|
|
2007
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
1,709
|
|
$
|
3,800
|
|
$
|
7,101
|
|
$
|
8,460
|
|
Cost of sales
|
|
820
|
|
1,282
|
|
3,020
|
|
3,639
|
|
Gross profit
|
|
889
|
|
2,518
|
|
4,081
|
|
4,821
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general
and administrative expenses
|
|
1,645
|
|
2,129
|
|
5,659
|
|
5,659
|
|
Amortization of
intangible assets
|
|
276
|
|
146
|
|
808
|
|
329
|
|
Operating
income(loss)
|
|
(1,032
|
)
|
243
|
|
(2,386
|
)
|
(1,167
|
)
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
|
23
|
|
6
|
|
178
|
|
Interest expense
|
|
(350
|
)
|
(319
|
)
|
(941
|
)
|
(706
|
)
|
Other income
(expense)
|
|
(1
|
)
|
|
|
1
|
|
|
|
Loss from
continuing operations before income taxes
|
|
(1,383
|
)
|
(53
|
)
|
(3,320
|
)
|
(1,695
|
)
|
|
|
|
|
|
|
|
|
|
|
Provision
(benefit) for income taxes
|
|
(340
|
)
|
475
|
|
(220
|
)
|
504
|
|
Loss from
continuing operations
|
|
(1,043
|
)
|
(528
|
)
|
(3,100
|
)
|
(2,199
|
)
|
|
|
|
|
|
|
|
|
|
|
Income from
discontinued operations
|
|
|
|
|
|
|
|
35
|
|
Net loss
|
|
(1,043
|
)
|
(528
|
)
|
(3,100
|
)
|
(2,164
|
)
|
|
|
|
|
|
|
|
|
|
|
Preferred stock
dividends
|
|
(140
|
)
|
(90
|
)
|
(350
|
)
|
(264
|
)
|
Net loss
applicable to common stockholders
|
|
$
|
(1,183
|
)
|
$
|
(618
|
)
|
$
|
(3,450
|
)
|
$
|
(2,428
|
)
|
|
|
|
|
|
|
|
|
|
|
Net loss per
common share, basic and diluted
|
|
|
|
|
|
|
|
|
|
Continuing
operations
|
|
$
|
(0.03
|
)
|
$
|
(0.01
|
)
|
$
|
(0.08
|
)
|
$
|
(0.06
|
)
|
Discontinued
operations
|
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
Net loss per
common share, basic and diluted
|
|
$
|
(0.03
|
)
|
$
|
(0.01
|
)
|
$
|
(0.08
|
)
|
$
|
(0.06
|
)
|
|
|
|
|
|
|
|
|
|
|
Weighted average
common shares outstanding, basic and diluted
|
|
42,470
|
|
42,337
|
|
42,381
|
|
40,205
|
|
See
Notes to Condensed Consolidated Financial Statements
4
Nextera Enterprises, Inc.
Condensed Consolidated Statements
of Cash Flows
(Amounts in thousands; unaudited)
|
|
Nine Months Ended
September 30,
|
|
|
|
2007
|
|
2006
|
|
Operating
activities
|
|
|
|
|
|
Net loss
|
|
$
|
(3,100
|
)
|
$
|
(2,164
|
)
|
Adjustments to
reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
Depreciation
|
|
52
|
|
36
|
|
Amortization of
intangible assets
|
|
808
|
|
329
|
|
Provision for
allowances and returns
|
|
1,033
|
|
|
|
Inventory
write-down
|
|
163
|
|
|
|
Deferred taxes
|
|
180
|
|
504
|
|
Stock based
compensation
|
|
184
|
|
175
|
|
Gain on sale of
fixed assets
|
|
(1
|
)
|
|
|
Change in
operating assets and liabilities:
|
|
|
|
|
|
Accounts
receivable
|
|
(2,481
|
)
|
(1,043
|
)
|
Inventories
|
|
449
|
|
843
|
|
Prepaid expenses
and other assets
|
|
(151
|
)
|
(126
|
)
|
Accounts payable
and accrued expenses
|
|
(2,054
|
)
|
633
|
|
Net cash used in
operating activities
|
|
(4,918
|
)
|
(813
|
)
|
|
|
|
|
|
|
Investing
activities
|
|
|
|
|
|
Cash recovered
from acquisition escrow
|
|
2,000
|
|
|
|
Acquisition of
business, net of cash acquired
|
|
|
|
(22,967
|
)
|
Purchase of
intellectual property and licensing agreement
|
|
(276
|
)
|
|
|
Purchase of
fixed assets
|
|
(23
|
)
|
(59
|
)
|
Net cash
provided by (used in) investing activities
|
|
1,701
|
|
(23,026
|
)
|
|
|
|
|
|
|
Financing
activities
|
|
|
|
|
|
Borrowing
(payments) under revolving credit facility
|
|
532
|
|
2,068
|
|
Borrowings under
term note
|
|
|
|
10,000
|
|
Payment of term
note
|
|
|
|
(250
|
)
|
Payment of note
acquired in acquisition
|
|
|
|
(1,000
|
)
|
Payment of debt
issuance costs
|
|
|
|
(490
|
)
|
Proceeds from
issuance of note payable
|
|
2,500
|
|
|
|
Net cash
provided by financing activities
|
|
3,032
|
|
10,328
|
|
|
|
|
|
|
|
Net decrease in
cash and cash equivalents
|
|
(185
|
)
|
(13,511
|
)
|
|
|
|
|
|
|
Cash and cash
equivalents at beginning of period
|
|
597
|
|
15,043
|
|
Cash and cash
equivalents at end of period
|
|
$
|
412
|
|
$
|
1,532
|
|
|
|
|
|
|
|
Supplemental
Disclosure of Cash Flow Information
|
|
|
|
|
|
Cash paid during
the period for:
|
|
|
|
|
|
Interest
|
|
$
|
730
|
|
640
|
|
Income Taxes
|
|
1
|
|
|
|
Non-cash
financing activity:
|
|
|
|
|
|
Conversion of
note payable to preferred stock and warrant
|
|
2,500
|
|
|
|
See
Notes to Condensed Consolidated Financial Statements
5
NEXTERA ENTERPRISES, INC.
NOTES TO UNAUDITED
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1.
Basis
of Presentation
The accompanying
unaudited condensed consolidated financial statements of Nextera Enterprises,
Inc. (Nextera or the Company) for the three months and nine months ended
September 30, 2007 and 2006 have been prepared in accordance with generally
accepted accounting principles for interim financial information and with the
instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by generally
accepted accounting principles for complete financial statements. In the
opinion of management, all adjustments (consisting of normal recurring
adjustments) considered necessary for a fair presentation have been included. Operating
results for the nine-month period ended September 30, 2007 are not necessarily
indicative of the results that may be expected for the year ending December 31,
2007.
The condensed
consolidated balance sheet as of December 31, 2006 has been derived from the
audited financial statements at that date but does not include all of the
information and footnotes required by U.S. generally accepted accounting
principles for complete financial statements.
These condensed
consolidated financial statements should be read in conjunction with the
consolidated financial statements and notes thereto, together with managements
discussion and analysis of financial condition and results of operations,
contained in the Companys Annual Report on Form 10-K filed by the Company with
the Securities and Exchange Commission on April 17, 2007.
On March 9, 2006, the
Company, through a wholly-owned subsidiary, acquired substantially all of the
assets of Jocott Enterprises, Inc. (Jocott), formerly Woodridge Labs, Inc.
Subsequently, the wholly owned subsidiary was renamed Woodridge Labs, Inc. As
used herein, the term Woodridge refers to Jocott for all periods prior to
March 9, 2006 and to Nexteras wholly owned subsidiary Woodridge Labs, Inc.
from and after March 9, 2006. Prior to the acquisition of the Woodridge assets,
Nextera had no business operations for the period from November 29, 2003
through March 8, 2006. Woodridges financial results have been included for the
period subsequent to the acquisition date, March 9, 2006.
Woodridge, Nexteras sole
operating business, is an independent developer and marketer of branded
consumer products that offer solutions to niche personal care needs. Brands
sold by Woodridge include Vita-K Solution, DermaFreeze 365
TM
, Ellin
LaVar Textures
TM
, Heavy Duty, Virtual laser
TM
, Pssssst®,
Bath Lounge
TM
, Vita-C2
TM
, firminol-10® and Turboshave®.
Mounte
LLC (successor to Krest, LLC, Knowledge Universe LLC and Knowledge Universe,
Inc., Mounte)
controls a majority of the
voting rights of the Companys equity securities through its ownership of the
Companys Class A Common Stock, Class B Common Stock,
Series A
Cumulative Convertible Preferred Stock (Series A Preferred)
and Series B Cumulative Non-Convertible
Preferred Stock (Series B Preferred).
The accompanying condensed consolidated
financial statements have been prepared on the basis that the Company is a
going concern. In March 2007, the Company voluntarily recalled certain products
in its DermaFreeze365
product line, resulting in adjustments to accounts
receivable and inventory of $2.5 million and $0.2 million, respectively.
Primarily as a result of these factors, the Company negotiated revisions to its
financial covenants for 2007 with its lender (see footnote 8). The
Company was successful in revising its financial covenants to provide for the
deferral of certain covenants until 2008, as well as reducing the thresholds of
other covenants that remain in effect throughout 2007. Further, the
Company entered into various agreements with certain of its shareholders to
obtain $4.5 million in additional subordinated financing which was funded
during March and April 2007 and further amended its credit facility in November 2007 to obtain additional working capital
bridge financing of $2.5 million (see footnote 8). The Companys forecast
for 2007 anticipates compliance with all required financial covenants
throughout 2007; however, management of the Company can provide no assurances
that such compliance can be maintained. Should future events occur that
are not now anticipated, the Company could be in violation of some or all of
its covenants in 2007 and in 2008.
2.
Significant Accounting
Policies
Principles of Consolidation
The
condensed consolidated financial statements include the accounts of the Company
and its subsidiaries. Significant intercompany accounts and transactions have
been eliminated in the consolidation.
6
Use of
Estimates
The
preparation of condensed consolidated financial statements in conformity with
U.S. generally accepted accounting principles requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosures of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reported period. Actual results could differ from those estimates.
Cash
and Cash Equivalents
Cash and cash equivalents
consist of cash on hand and demand deposit accounts. The Company considers all
highly liquid investments with maturity of three months or less when purchased
to be cash equivalents. Cash equivalents are stated at cost, which approximates
market value.
Concentration of Credit Risk
Financial instruments
that potentially subject the Company to concentrations of credit risk consist
principally of cash and cash equivalents and accounts receivable. The Company
places its cash and cash equivalents in various financial institutions with
high credit ratings and, by policy, limits the amount of credit exposure to any
one financial institution.
Concentrations of credit
risk with respect to accounts receivable exist due to a limited number of
customers that make up the Companys customer base. Three customers accounted
for 82% of gross accounts receivable as of September 30, 2007. The Company
performs ongoing credit evaluations of its customers and generally does not
require collateral. The Company maintains allowances for doubtful accounts for
specifically identified estimated losses resulting from the inability of its
customers to make required payments. Gross sales (net sales prior to customer
deductions) to the Companys three largest customers made up 73% and 63% of
total gross sales for the three-month and nine-month periods ending September
30, 2007.
Revenue Recognition,
Allowances for Sales Returns
and Markdowns
Sales
are recognized when title and risk of loss transfer to the customer, the sales
price is fixed or determinable and the collection of the resulting receivable
is probable. Sales are recorded net of estimated returns and other allowances.
The provision for sales returns represents managements estimate of future
returns based on historical experience and considering current external factors
and market conditions.
The sales-return accrual
is a subjective critical estimate that has a direct impact on reported net
sales. As is customary in the industry, the Company grants certain of its
customers, subject to authorization and approval, the right to either return
products or to receive a markdown allowance for certain promotional product.
Upon sale, the Company records a provision for product returns and markdowns
estimated based on historical and projected experience, economic trends and
changes in customer demand. There is considerable judgment used in evaluating
the factors influencing the allowance for returns and markdowns, and therefore
additional allowances in any particular period may be needed. The types of known
or anticipated events that the Company has considered, and will continue to
consider, include, but are not limited to, the solvency of its customers, store
closings by retailers, changes in the retail environment, including mergers and
acquisitions, and the Companys decision to continue or support new and
existing products. Actual sales returns and markdowns may differ significantly,
either favorably or unfavorably, from these estimates.
Advertising
, Promotion
and Marketing
All costs associated with
advertising, promoting and marketing (including promotions, direct selling,
co-op advertising and media placement) of Company products are expensed as
incurred and charged to selling, general and administrative expense. For the
three months ended September 30, 2007 and 2006, advertising and promotion
expenses were $0.2 million and $0.6 million, respectively. For the nine
months ended September 30, 2007 and 2006, advertising and promotion expenses
were $0.8 million and $1.6 million, respectively
Shipping
and
Handling Costs
Substantially all costs
associated with shipping and handling of products to customers are included in
selling, general and administrative expense. For the three months ended
September 30, 2007 and 2006, shipping and handling costs were approximately
$0.1 million and $0.1 million, respectively. For the nine months ended
September 30, 2007 and 2006, shipping and handling costs were approximately
$0.3 million and $0.3 million, respectively.
7
Inventories
Inventories are stated at
the lower of cost (using the first-in, first-out method) or market value.
Provisions for Inventory Obsolescence
The Company records a
provision for estimated obsolescence of inventory. These estimates consider the
cost of inventory, forecasted demand, the estimated market value, the shelf
life of the inventory and historical experience. If there are changes to these
estimates, additional provisions for inventory obsolescence may be necessary.
Property and Equipment
Property and equipment
are stated at cost. Depreciation of property and equipment is provided on the
straight line method based on the estimated lives of the assets. The principal
estimated useful lives used in computing depreciation and amortization are as
follows:
Equipment and vehicles
|
|
3 - 5 years
|
Furniture and fixtures
|
|
3 - 5 years
|
Software
|
|
3 years
|
Leasehold improvements
are amortized over the shorter of the life of the lease or the estimated useful
life of the asset.
Accounting for Acquisitions and Intangible Assets
The Company has accounted for its acquisitions under the purchase
method of accounting for business combinations. Under the purchase method of
accounting, the costs, including transaction costs, are allocated to the
underlying net assets, based on their respective estimated fair values. The
excess of the purchase price over the estimated fair values of the net assets
acquired is recorded as goodwill.
The judgments made in
determining the estimated fair value and expected useful lives assigned to each
class of assets and liabilities acquired can significantly affect net income.
For example, different classes of assets will have useful lives that differ and
the useful life of property, plant and equipment acquired will differ substantially
from the useful life of brand licenses and trademarks. Consequently, to the
extent a longer-lived asset is ascribed greater value under the purchase method
than a shorter-lived asset, net income in a given period may be higher.
Determining
the fair value of certain assets and liabilities acquired is judgmental in
nature and often involves the use of significant estimates and assumptions. One
of the areas that requires more judgment is determining the fair value and
useful lives of intangible assets. To assist in this process, the Company often
obtains appraisals from independent valuation firms for certain intangible
assets.
The
Companys intangible assets primarily consist of customer relationships,
non-compete covenants, exclusive brand licenses and trademarks. The value of
the intangible assets, including customer relationships and other intangibles,
is exposed to future adverse changes if the Company experiences declines in
operating results or experiences significant negative industry or economic
trends. The Company periodically reviews intangible assets, at least annually
or more often as circumstances dictate, for impairment and the useful life
assigned using the guidance of applicable accounting literature.
Long-Lived Assets
The Company reviews for
the impairment of long-lived assets to be held and used whenever events or
changes in circumstances indicate that the carrying amount of such assets may
not be fully recoverable. Measurement of an impairment loss is based on the
fair value of the asset compared to its carrying value. Long-lived assets to be
disposed of are reported at the lower of carrying amount or fair value less
costs to sell.
8
Deferred
Financing Costs
The Company has incurred
costs in connection with its credit agreement. Costs directly associated with
financings are capitalized as deferred financing costs and are amortized over
the weighted average life of the long-term credit facility.
Basic and Diluted Earnings Per Common Share
The
Company presents two earnings per share amounts: the basic earnings per common
share and the diluted earnings per common share. Basic earnings per common
share includes only the weighted average shares outstanding and excludes any
dilutive effects of options, warrants and convertible securities. The dilutive
effects of options, warrants and convertible securities are added to the
weighted average shares outstanding in computing diluted earnings per common
share. For the three and nine-month periods ended September 30, 2007 and 2006,
basic and diluted earnings per common share are the same due to the
antidilutive effect of potential common shares outstanding.
Income Taxes
The Company adopted the
provisions of Financial Accounting Standards Board (FASB) Interpretation No.
48, Accounting for Uncertainty in Income Taxes, an interpretation of FASB
Statement No. 109 (FIN 48), on January 1, 2007. The impact of
adopting FIN 48 was not material to the Companys financial position or results
of operations. Excluding the federal benefits on state tax positions and
federal and state benefits on interest which have been recorded as deferred
income taxes, there are no unrecognized tax benefits.
There
are no income tax examinations currently in process.
Share-Based Compensation
All
share-based payments to employees, including the grant of employee stock
options, are recognized in the condensed consolidated financial statements
based on their fair value. Compensation cost for awards that vest will not be
reversed if the awards expire without being exercised. The fair value of stock
options is determined using the Black-Scholes option-pricing model.
Compensation costs for awards are amortized using the straight-line method.
Option pricing model input assumptions such as expected term, expected
volatility and risk-free interest rate impact the fair value estimate. Further,
the forfeiture rate impacts the amount of aggregate compensation. These
assumptions are subjective and generally require significant analysis and
judgment to develop. When estimating fair value, some of the assumptions are
based on or determined from external data and other assumptions are derived
from historical experience. The appropriate weight to place on historical
experience is a matter of judgment, based on relevant facts and circumstances.
The
Company relies on its historical experience and post-vested termination
activity to provide data for estimating its expected term for use in
determining the fair value of its stock options. The Company currently
estimates its stock volatility by considering its historical stock volatility
experience and other key factors. The risk-free interest rate is the implied
yield currently available on U.S. Treasury zero-coupon issues with a remaining term
equal to the expected term used as the input to the Black-Scholes model. The
Company estimates forfeitures using its historical experience. The estimates of
forfeitures will be adjusted over the requisite service period based on the
extent to which actual forfeitures differ, or are expected to differ, from
their estimates.
Comprehensive Loss
Other than the net loss incurred during the
three-month periods ended September 30, 2007 and 2006, there were no additional
material other components of comprehensive loss.
Recently Issued Accounting Pronouncements
In September 2006, the
Financial Accounting Standards Board (FASB) issued Statement of Financial
Accounting Standards (SFAS) Statement No. 157,
Fair Value Measurements,
(SFAS 157).
SFAS 157 establishes a single authoritative definition of fair value, sets
out a framework for measuring fair value, and expands on required disclosures
about fair value measurement. SFAS 157 is effective for financial
statements issued for fiscal years beginning after November 15, 2007, and
interim periods within those years. Early adoption is permitted. The
9
Company plans to adopt SFAS No. 157 in the first quarter of
its 2008 fiscal year. The provisions of SFAS 157 are not expected to have
a material impact on the Companys consolidated financial statements.
In
September 2006, the Financial Accounting Standards Board (FASB) issued SFAS
158,
Employers Accounting for Defined Benefit Pension
and Other Postretirement Plansan amendment of FASB Statements No. 87, 88, 106,
and 132(R)
(SFAS 158). SFAS 158 requires an employer to recognize
the overfunded or underfunded status of a defined benefit postretirement plan
(other than a multiemployer plan) as an asset or liability in its statement of
financial position and to recognize changes in that funded status in the year
in which the changes occur through comprehensive income of a business entity or
changes in unrestricted net assets of a not-for-profit organization. This
Statement also improves financial reporting by requiring an employer to measure
the funded status of a plan as of the date of its year-end statement of
financial position, with limited exceptions. This statement is effective as of
the beginning of an entitys first fiscal year that begins after December 15,
2006. The provisions of SFAS 158 are not expected to have a material impact on
the Companys consolidated financial statements.
In
February 2007, the
Financial Accounting Standards Board (F
ASB) issued SFAS 159,
The Fair Value Option for Financial Assets and Financial Liabilities
Including an amendment of FASB Statement No. 115
(SFAS 159). SFAS
159 permits entities to choose to measure many financial instruments and
certain other items at fair value. This statement is effective as of the
beginning of an entitys first fiscal year that begins after November 15, 2007.
The Company is currently evaluating the impact of SFAS 159 on the Companys
consolidated financial statements.
Reclassifications
Certain
reclassifications were made to the 2006 financial statements in order that they
may be consistent with the 2007 presentation.
3.
Acquisitions
Woodridge Labs, Inc
On March 9, 2006, the
Company, through W Lab Acquisition Corp., the Companys wholly owned
subsidiary, acquired substantially all of the assets of Jocott. Jocott formerly
operated under the name Woodridge Labs, Inc.
The assets of Jocott were acquired pursuant to an asset purchase
agreement, which agreement is referred to as the Woodridge Asset Purchase
Agreement in these financial statements. The acquisition of the assets of
Jocott and all related transactions are referred to in these financial
statements as the Woodridge Transaction.
Subsequently, W Lab Acquisition Corp. was renamed Woodridge Labs, Inc. As
used in these financial statements, the term Woodridge refers to Jocott for
all periods prior to March 9, 2006 and to the Companys wholly owned subsidiary
Woodridge Labs, Inc. from and after March 9, 2006. Woodridges financial
results have only been included for the period subsequent to the acquisition
date, March 9, 2006.
The purchase price
comprised:
$23.2
million in cash, including $0.8 million of acquisition expenses paid to third
parties;
8,467,410
unregistered restricted shares of Nexteras Class A Common Stock constituting
approximately 20% of the total outstanding common stock of Nextera immediately
after such issuance, which shares were issued to Jocott. Such shares had a
value of $4.2 million on the date of the Woodridge Transaction; and
the
assumption of a promissory note of Jocott in the principal amount of $1.0
million, which assumed debt was paid in full by the Company on the closing date
of the Woodridge Transaction.
$2.0 million of the cash
portion of the purchase price was originally placed in escrow through September
2007. On March 29, 2007, Nextera, Woodridge and Jocott entered into an
Indemnity Deposit Agreement, under which
$0.5 million was withdrawn from the escrow account that was established
in connection with the Woodridge Transaction and such funds were paid to
Nextera by Jocott as a deposit to be held by Nextera and Woodridge pending any
final determination under which Jocott was obligated under the Woodridge Asset
Purchase Agreement to indemnify Woodridge or Nextera for damages in connection
with the March 2007 product recall of certain DermaFreeze365 products
sold by Woodridge.
10
Nextera, Woodridge,
Mounte and Jocott entered into a Funding Agreement, dated April 16, 2007 (Funding
Agreement), whereby Jocott paid as an additional irrevocable indemnity
deposit, an amount equal to $1.5 million. The additional deposit was also made
by withdrawing such amount from the escrow account that was established in
connection with the Woodridge Transaction. The parties agreed that the terms
and conditions of the Funding Agreement will govern both the original and
additional indemnity deposits. The Jocott deposit of $2.0 million will not bear
interest and Nextera and Woodridge may use the deposit funds to satisfy any
liabilities, obligations or other requirements of either or both of Nextera and
Woodridge. The deposits will be deemed to be in satisfaction and payment in
full of any and all past, present and future claims for indemnification for any
breaches of any of the representations and warranties pursuant to the Woodridge
Asset Purchase Agreement that originally would have survived for only eighteen
months following the closing date of the Woodridge Transaction, but does not
apply to any claims for breaches of any representations or warranties that
survive beyond the eighteen month period. The deposits are the sole and
exclusive property of Nextera and Nextera has no liability or obligation to
account for or return or refund any portion of the deposits or any earnings on
the deposits. Accordingly, the entire $2.0 million was recorded as a reduction
of the purchase price and therefore a reduction of goodwill related to the
Woodridge Transaction in March 2007.
The
Woodridge Transaction was accounted for under the purchase method of accounting
in accordance with SFAS No. 141,
Business Combinations
(SFAS 141) Under the purchase method
of accounting, the total estimated purchase price is allocated to the net
tangible and intangible identifiable assets and liabilities based on their
estimated relative fair values. The excess purchase price over those assigned
values was recorded as goodwill. Goodwill recorded as a result of this
acquisition is deductible for tax purposes. The final purchase price allocation
is as follows (in thousands):
Current assets
|
|
$
|
4,559
|
|
Long-term assets
|
|
389
|
|
Goodwill
|
|
8,969
|
|
Intangible
assets
|
|
13,000
|
|
Total assets
acquired
|
|
$
|
26,917
|
|
Less liabilities
assumed
|
|
1,703
|
|
|
|
$
|
25,214
|
|
The following table sets forth the unaudited pro
forma results in thousands, except for share data, of the Companys operations
for the nine months ended September 30, 2006 as if the acquisition of Woodridge
had been completed on January 1, 2006.
The
unaudited pro forma results are not indicative of what the actual results would
have been had the acquisition been completed on January 1, 2006 nor do they
purport to indicate the results of the future operations of Nextera.
|
|
Nine months ended
September 30,
2006
|
|
Net sales
|
|
$
|
10,639
|
|
|
|
|
|
Loss from
continuing operations before income taxes
|
|
(110
|
)
|
|
|
|
|
Net loss
|
|
(649
|
)
|
Preferred stock
dividends
|
|
(264
|
)
|
Net loss
applicable to common stockholders
|
|
$
|
(385
|
)
|
|
|
|
|
Weighted average
common shares outstandingbasic and diluted
|
|
42,337
|
|
|
|
|
|
Basic and
diluted loss per share
|
|
$
|
(0.01
|
)
|
The amortization of the inventory step-up, which
represents an increase to the
inventory to reflect its fair value (less
selling profit) and results in an increase in cost of sales upon the sale of
the inventory, has been excluded from
the pro forma amounts as the costs are non-recurring.
11
LaVar Acquisition
On
May 23, 2006, Woodridge entered into a purchase agreement with LaVar Holdings,
Inc. (the LaVar Purchase Agreement), whereby Woodridge acquired the exclusive
worldwide license rights, along with certain other assets and proprietary
rights, to the Ellin LaVar Textures
Ô
hair care product line and brand name. The total purchase price, which includes
approximately $0.1 million of transactions costs, was approximately $0.5
million. Under the terms of the LaVar Purchase Agreement, Woodridge will pay a
royalty to LaVar Holdings, Inc. with respect to certain future sales of
products under the acquired trademarks.
Heavy Duty Acquisition
On
March 8, 2007, Woodridge entered into a purchase agreement with Heavy Duty
Company (the Heavy Duty Purchase Agreement), whereby Woodridge acquired the
exclusive worldwide license rights, along with certain other assets and
proprietary rights, to the Heavy Duty
Ô
personal care product line and brand name. The total purchase price, which
includes approximately $0.1 million of transactions costs, was approximately
$0.3 million. Under the terms of the Heavy Duty Purchase Agreement, Woodridge
will pay a royalty to the Heavy Duty Company with respect to certain future
sales of products under the acquired trademarks.
4.
Inventories
Inventories, net of provision for obsolescence,
consist of the following:
|
|
September 30,
2007
|
|
December 31,
2006
|
|
|
|
(In thousands)
|
|
|
|
|
|
|
|
Raw materials
|
|
$
|
910
|
|
$
|
1,217
|
|
Finished goods
|
|
1,073
|
|
1,378
|
|
|
|
$
|
1,983
|
|
$
|
2,595
|
|
5.
Intangible
Assets
Intangible assets consist
of the following:
|
|
September 30,
|
|
December 31,
|
|
|
|
2007
|
|
2006
|
|
|
|
(In thousands)
|
|
|
|
|
|
|
|
Goodwill
|
|
$
|
8,969
|
|
$
|
10,969
|
|
|
|
|
|
|
|
Trademarks and
brands
|
|
2,200
|
|
2,200
|
|
Covenant not to
compete
|
|
1,600
|
|
1,600
|
|
Customer
relationships
|
|
9,200
|
|
9,200
|
|
Licensing
agreements
|
|
785
|
|
489
|
|
Other
|
|
37
|
|
64
|
|
|
|
13,822
|
|
13,553
|
|
Less:
accumulated amortization
|
|
1,445
|
|
726
|
|
Intangible
assets, net
|
|
$
|
12,377
|
|
$
|
12,827
|
|
The intangible assets, other than the covenant not
to compete, are amortized over their estimated useful lives, which range from
10-20 years. The covenant not to compete is amortized over its contractual life
of 9 years.
The estimated intangible
amortization expense for the next five years is as follows:
|
|
Amortization Expense
|
|
|
|
(In thousands)
|
|
|
|
|
|
2007
|
|
$
|
244
|
|
2008
|
|
936
|
|
2009
|
|
937
|
|
2010
|
|
936
|
|
2011
|
|
937
|
|
2012
|
|
936
|
|
Thereafter
|
|
7,451
|
|
|
|
|
|
|
12
6.
Property
and Equipment
Property and equipment
are stated at cost and are summarized by major classification as follows:
|
|
September 30,
|
|
December 31,
|
|
|
|
2007
|
|
2006
|
|
|
|
(In thousands)
|
|
|
|
|
|
|
|
Equipment
|
|
$
|
166
|
|
$
|
182
|
|
Tools and dies
|
|
107
|
|
85
|
|
Software
|
|
17
|
|
25
|
|
Furniture and
fixtures
|
|
26
|
|
53
|
|
Leasehold
Improvements
|
|
19
|
|
19
|
|
|
|
335
|
|
364
|
|
Less:
accumulated depreciation
|
|
79
|
|
80
|
|
Property and
equipment, net
|
|
$
|
256
|
|
$
|
284
|
|
7.
Accounts
Payable and Accrued Expenses
Accounts
payable and accrued expenses consist of the following:
|
|
September 30,
2007
|
|
December 31,
2006
|
|
|
|
(In thousands)
|
|
|
|
|
|
|
|
Trade accounts
payable
|
|
$
|
422
|
|
$
|
1,717
|
|
Accrued credit
customer balances
|
|
834
|
|
1,859
|
|
Accrued payroll
and compensation
|
|
176
|
|
129
|
|
Accrued legal,
audit and annual report costs
|
|
178
|
|
134
|
|
Accrued
severance
|
|
|
|
270
|
|
Accrued interest
|
|
130
|
|
65
|
|
Accrued
commission
|
|
42
|
|
|
|
Other
|
|
94
|
|
190
|
|
|
|
$
|
1,876
|
|
$
|
4,364
|
|
8.
Financing Arrangements
In
connection with the acquisition of substantially all of the assets of Jocott,
Nextera and Woodridge (as borrower) entered into a credit agreement on
March 9, 2006 for a $15.0 million senior secured credit facility, which
was originally comprised of a $10.0 million fully-drawn term loan and a
four-year $5.0 million revolving credit facility (the Credit Agreement). The
Credit Agreement was subsequently amended on March 29, 2007,
April 17, 2007 and again on November 7, 2007.
Effective
March 29, 2007, Nextera, Woodridge, the administrative agent for the
lenders, and the lenders, entered into an amendment and forbearance agreement
(the Amendment and Forbearance Agreement). The Amendment and Forbearance
Agreement amended and modified certain terms of the original Credit Agreement.
Under the terms of the Amendment and Forbearance Agreement, the date by which
Nextera and Woodridge were required to deliver Nexteras audited consolidated
financial statements as of and for the year ended December 31, 2006 and
related certificates and reports to the administrative agent was postponed from
March 31, 2007 to April 30, 2007. Additionally, a principal payment of
$250,000 that was due on March 31, 2007 was postponed to April 30, 2007.
The
administrative agent for the lenders under the Credit Agreement determined
that, as of March 29, 2007, certain events of default under the Credit
Agreement (which events of default are referred to as the Specified Events of
Default in these financial statements) had occurred as a consequence of the
breach by Nextera and Woodridge of certain financial covenants as of
December 31, 2006. Under the Amendment and Forbearance Agreement, the
lenders
13
agreed, during the
forbearance period, to forbear the exercise of any and all rights and remedies
to which the lenders are or may become entitled as a result of the Specified
Events of Default. The forbearance period began on March 29, 2007 and
ended on April 30, 2007.
On
April 17, 2007, Nextera, Woodridge, the administrative agent and the
lenders entered into an amendment agreement under the Credit Agreement (the Second
Amendment). Under the terms of the Second Amendment, the revolving credit
facility was reduced from $5.0 million to $2.75 million. Pursuant to the Second
Amendment, the term loan and the revolving credit facility bear interest at the
London Interbank Offered Rate (LIBOR) plus 4.50%, or bank base rate plus
3.25%, as selected by Woodridge.
On
November 7, 2007, Nextera, Woodridge, Mounte, the administrative agent and the
lenders entered into an amendment agreement under the Credit Agreement (the Third
Amendment). Under the terms of the Third Amendment, the Company obtained a
bridge loan credit facility aggregating $2.5 million. Pursuant to the Third
Amendment, the bridge loan facility , the term loan and the revolving credit
facility will bear interest at the London Interbank Offered Rate (LIBOR) plus
5.0%, or bank base rate plus 4.0%, as selected by Woodridge. Outstanding
borrowings under the bridge loan facility must be repaid with cash balances in
excess of $500,000 through the final maturity of May 31, 2008. Outstanding
borrowings under the term loan must be repaid in 4 quarterly payments,
commencing March 31, 2008, with a final payment due on March 31,
2009, the maturity date of the term loan. The maturity date for the revolving
credit facility is also March 31, 2009. The commitment fee on the
revolving credit facility is payable quarterly at a rate of 0.50% of the unused
amount of the revolving credit facility per annum. Additionally, the financial
covenants were waived for periods prior to November 7, 2007 and modified
thereafter.
The
Company has an interest rate collar agreement to hedge the LIBOR interest rate
risk on $5.0 million of the term loan. Under the terms of this agreement, the
Company will pay a 6% fixed rate if the three-month LIBOR rate exceeds 6% and
in return will receive the three-month LIBOR rate. In addition, if the
three-month LIBOR rate falls below 5%, the Company will pay a 5% fixed rate and
in return will receive the three-month LIBOR rate. The effect of this agreement
is therefore to convert the floating three-month LIBOR rate to a fixed rate if
the three-month LIBOR rate exceeds 6% or falls below 5%. The three-month LIBOR
rate received under the agreement will substantially match the rate paid on the
term loan since term loan currently bears interest at the six-month LIBOR rate.
The fair value of the collar was ($56,000) at September 30, 2007.
The
obligations of Woodridge, as borrower, under the Credit Agreement are
guaranteed by Nextera and all of the direct and indirect domestic subsidiaries
of Woodridge and Nextera existing from time to time (other than Nextera
Business Performance Solutions Group, Inc., Nextera Canada Co. and Nextera
Economics, Inc.), which are referred to as the Subsidiary Guarantors in
these financial statements. In addition, Nextera, Woodridge and the Subsidiary
Guarantors are party to a security agreement and a pledge agreement, which
create security and pledge interests with respect to substantially all present
and future property of Nextera, Woodridge and the Subsidiary Guarantors.
Under
the Credit Agreement, as amended, Nextera and Woodridge are subject to certain
limitations, including limitations on their ability: to incur additional debt
or sell assets, with restrictions on the use of proceeds; to make certain
investments and acquisitions; to grant liens; and to pay dividends and make
certain other restricted payments. In addition, Woodridge will be required to
prepay principal amounts outstanding under certain circumstances if it issues
debt or equity, sells assets or property, receives certain extraordinary
receipts or generates excess cash flow. The Credit Agreement, as amended, also
contains certain restrictive financial covenants, including minimum
consolidated earnings before interest,
taxes, depreciation and amortization (EBITDA), minimum purchase order
levels and maximum corporate overhead, as defined..
Upon
the occurrence of certain events of default, Woodridges obligations under the
Credit Agreement may be accelerated and the lending commitments terminated.
Such events of default include, but are not limited to: (i) the failure of
Woodridge to pay principal or interest when due, (ii) Woodridges breach
or failure to perform any of the covenants or obligations set forth in the
Credit Agreement, which for certain covenants and obligations is subject to a
30-day cure period, (iii) the acceleration of certain other indebtedness
of Woodridge, (iv) a filing of a petition in bankruptcy by Woodridge,
(v) the entry of a judgment or a court order against Woodridge in excess
of certain specified dollar thresholds, (vi) a reduction below certain
levels in the ownership or economic interests of our existing significant
stockholders in the aggregate or (vii) Mr. Millin ceasing to be a
member of Nexteras board of directors or the chief executive officer of
Woodridge prior to March 9, 2010, except for certain specified reasons.
14
Long-term
debt consists of the following (in thousands):
|
|
September 30,
2007
|
|
Term loan
|
|
$
|
9,500
|
|
Revolving credit
facility
|
|
|
|
|
|
9,500
|
|
Less: Current
portion of long-term debt
|
|
750
|
|
|
|
$
|
8,750
|
|
Future
principal payments required in accordance with the terms of the Credit
Agreement are as follows (in thousands):
Twelve months
ending September 30,
|
|
|
|
2008
|
|
$
|
750
|
|
2009
|
|
8,750
|
|
|
|
$
|
9,500
|
|
Funding
Agreement and Note Conversion Agreements
On
April 16, 2007, Nextera, Woodridge, Mounte and Jocott entered into a
Funding Agreement (the Funding Agreement). Under the terms of the Funding
Agreement, Mounte and Jocott loaned to Nextera the principal sums of $1.5
million and $1.0 million respectively, pursuant to individual promissory notes.
The notes accrued interest at an annual rate of 7% with principal originally
payable at the maturity date of April 1, 2012. Nextera was prohibited from
paying interest in cash on these notes under the terms of its Credit Agreement.
Accordingly, interest was accrued and added to the principal balance of the
notes. The notes, including accrued interest, were exchanged in connection with
the Note Conversion Agreement discussed below.
The
Funding Agreement provides, subject to (i) any required consents or approvals
of the lenders under the Credit Agreement and of any other persons whose
consent or approval is required at the time under any credit or other contract
or agreement to which Nextera, Woodridge or any of their affiliates is a party,
(ii) any required consent of the holders of the outstanding Series A Preferred,
and (iii) the approval of the Board; that, in the event that Nexteras EBITDA
for a fiscal year is greater than or equal to $7.0 million or is greater than
or equal to $12.0 million for any two consecutive fiscal years, or any event
happens that results in the exchange or redemption of, or payment of a
liquidation preference with respect to, any of Nexteras outstanding preferred
stock (the Triggering Event), Nextera will take the following actions:
a)
Within 15
business days after the occurrence of a Triggering Event, Nextera will issue to
Jocott additional shares of Cumulative Non-convertible Series B Preferred Stock
(Series B Preferred) in addition to the shares of Series B Preferred issued
in connection with the Note Conversion Agreement, at a price equal to $100 per
share. The number of such additional shares to be issued to Jocott will be
equal to the quotient obtained by dividing (i) the sum of (A) $1,000,000, plus
(B) the Appreciation Amount defined below, by (ii) 100, and rounding down to
the nearest whole share. Such shares of Series B Preferred will be issued to
Jocott in consideration of Jocotts irrevocable payment of the $2.0 million
indemnity deposit and Jocotts compromise and settlement of the past, pending
and future specified claims. The Appreciation Amount means an amount equal to
a deemed appreciation equal to (1) $1,000,000, multiplied by (2) seven percent
(7%) per annum, compounded annually, calculated from the date that Jocott
loaned the funds to Nextera pursuant to the promissory note issued by Jocott until
the date of the issuance of the additional shares of Series B Preferred to
Jocott.
b)
Within 15
business days after the occurrence of a Triggering Event, Nextera will also
issue to Jocott the same number of shares of Series C Cumulative
Non-Convertible Preferred Stock (Series C Preferred) of Nextera as the number
of additional shares of Series B Preferred issued to Jocott. The Series C
Preferred will (i) be issued at a price equal to $100 per share, (ii) have a
liquidation preference equal to $100 per share and (iii) provide for a 7%
paid-in-kind dividend. The Series C Preferred will not be convertible into any
other securities of Nextera and the Series C Preferred will rank (i) junior to
the Series A Preferred as to the payment of dividends and as to the
distribution of assets upon liquidation, dissolution or winding up, and (ii) on
a parity with the Series B Preferred as to the payment of dividends and the
Special Redemption Right noted below, but rank junior to the Series B Preferred
as to the distribution of assets upon liquidation, dissolution or winding up.
The Series C Preferred will be structured so as to comply with any applicable
restrictions in any credit or other contract or agreement to which Nextera,
Woodridge or any of their affiliates is a party. Such
15
shares of Series C
Preferred will be issued to Jocott in consideration of Jocotts irrevocable
payment of the $2.0 million indemnity deposit and Jocotts compromise and
settlement of the past, pending and future specified claims.
c)
Nextera will
grant to the holders of Series A Preferred, Series B Preferred and Series C
Preferred the right (the Special Redemption Right), the exercise of which is
conditioned upon the occurrence of a Triggering Event, the request of the
holders and the approval of the Companys board of directors, to redeem all or a portion of the shares of
the Preferred Stock held by such holders at a redemption price equal to $100
per share (plus any applicable accrued but unpaid dividends on the shares so
redeemed). The Special Redemption Right of the holders of Series A Preferred
will be senior and prior to the Special Redemption Rights of the holders of
Series B Preferred and Series C Preferred, and the Special Redemption Rights of
the holders of Series B Preferred and Series C Preferred will be on a parity
with each other.
Additionally,
under the provisions of the Funding Agreement, in connection with and at the
time of the issuance of any Series B Preferred and/or Series C
Preferred, Nextera issued warrants to purchase Nexteras Class A Common
Stock at an exercise price of $0.50 per share (the Warrants) to the holder of
such Series B Preferred and/or Series C Preferred. The number of
shares of Nexteras Class A Common Stock for which such warrants are
exercisable is equal to (i) with respect to notes redeemed or exchanged
for Series B Preferred , the product of (A) the outstanding principal
balance plus all accrued but unpaid interest that was redeemed or exchanged, multiplied
by (B) two (2); (ii) 2,000,000 shares with respect to the
Series B Preferred Stock issued upon the occurrence of a Triggering Event
(when and if such Series B Preferred is issued), and (iii) 2,000,000
shares with respect to the Series C Preferred issued upon the occurrence
of a Triggering Event (when and if such Series C Preferred is issued). The
Warrants will have a ten (10) year term and have customary piggyback
registration rights and anti-dilution rights and other rights with respect to
specified events, all as determined by Nexteras board of directors.
On
June 15, 2007, Nextera entered into a Note Conversion Agreement whereby
Nextera exchanged all outstanding principal and accrued interest owed to Mounte
and Jocott pursuant to individual promissory notes executed in connection with
the Funding Agreement for 15,169 and 10,113 shares, respectively, of Nexteras
Series B Preferred together with a cash payment in lieu of fractional shares.
The Series B Preferred Stock was issued at a price of $100 per share, has
a liquidation preference of $100 per share, provides for a 7% per annum
cumulative paid-in-kind dividend, and entitles its holders to a number of votes
equal to the number of shares held. The Series B Preferred Stock is not
convertible into any other securities of Nextera and ranks junior to the
Series A Preferred Stock as to the payment of dividends, the issuance of a
special redemption, and the distribution of assets upon liquidation,
dissolution or winding up. The Series B Preferred Stock is structured so
as to qualify as Permitted Equity Interests as such term is defined in
Nexteras Credit Agreement, as amended.
In connection with the
issuance of the issuance of the Series B Preferred Stock, Nextera issued a
Class A Common Stock Purchase Warrant to, each of Mounte and Jocott,
pursuant to the terms of a Funding Agreement. Under such Warrants, Nextera
granted Mounte and Jocott the right to purchase 3,033,945 and 2,022,630 shares,
respectively, of Nexteras Class A Common Stock at an exercise price of
$0.50 per share, exercisable at any time at the option of the holder. The
warrants have a ten-year term and have customary piggyback registration rights
and anti-dilution rights with respect to specified events. The fair value of
the warrants has been determined to be $647 thousand. This amount was
calculated using the Black-Scholes pricing model with the following
assumptions: 118.9% volatility; expected term of 10 years; 5.10% risk-free
rate; and 0% dividend.
The Series B Preferred is
classified as mezzanine equity as the Redemption Rights are effectively
redeemable at the option of the holders and are not solely within the control
of the issuer. The initial carrying amount of the Series B Preferred is the
fair value at issuance. The Series B Preferred will not be accreted to the
redemption value of $2.5 million until redemption is considered probable. The
7% paid-in-kind dividend accrues to the carrying value of the Series B
Preferred.
9.
Share-Based Compensation
For
the three months ended September 30, 2007 and 2006, the compensation cost
charged against income was $0.03 million and $0.07 million, respectively. For
the nine months ended September 30, 2007 and 2006, the compensation cost
charged against income was $0.2 million and $0.2 million, respectively. As of
September 30, 2007, there were approximately $0.2 million of unrecognized
compensation costs related to non-vested share-based arrangements granted under
the Companys Amended and Restated 1998 Equity Participation Plan (the Plan).
Those costs are expected to be recognized over a weighted-average period of
approximately one year.
During
the three months ended September 30, 2007, the Company granted stock options
for an aggregate of 400,000 shares of Class A Common Stock under the Plan to a
non-employee with an Independent Contractor
16
agreement with KKG BodyFuel
Foods Enterprises. The weighted-average grant-date fair value of options
granted was $0.13 per share based on the Black-Scholes option-pricing model.
The options expire ten years from the date of grant.
The
weighted-average grant date fair value of options granted during the nine
months ended September 30, 2007 was estimated on the grant date using the
Black-Scholes option-pricing model with the assumptions noted in the following
table. Expected volatilities are based on historical volatility of the
Common Stock and other factors. The expected term of options represents
the period of time that options granted are expected to be outstanding and is
derived from historical terms and other factors. The risk-free rate for
periods within the contractual life of the option is based on the U.S. Treasury
yield curve in effect at the time of grant.
|
|
Nine months ended
September 30, 2007
|
|
|
|
|
|
Risk-free
interest rates
|
|
4.75%
|
-
|
5.10%
|
|
Expected lives
(years)
|
|
3
|
-
|
5
|
|
Expected
volatility
|
|
58.3%
|
-
|
118.9%
|
|
Dividend rate
|
|
0%
|
|
Stock Option Activity
Options
granted, exercised, expired and forfeited under the Plan are as follows:
Stock Options
|
|
Shares
|
|
Weighted
Average Exercise
Price Per Share
|
|
Weighted-Average
Remaining
Contractual Life
|
|
Aggregate
Intrinsic Value
|
|
Outstanding at
December 31, 2006
|
|
6,552,267
|
|
$
|
1.62
|
|
|
|
|
|
Granted
|
|
1,651,168
|
|
0.24
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
Forfeited or
expired
|
|
1,375,000
|
|
1.25
|
|
|
|
|
|
Options
Outstanding at September 30, 2007
|
|
6,828,435
|
|
$
|
1.36
|
|
6.0
|
|
$
|
|
|
Options vested
and expected to vest at September 30, 2007
|
|
6,204,732
|
|
$
|
1.46
|
|
5.0
|
|
$
|
|
|
Options
exercisable at September 30, 2007
|
|
5,286,977
|
|
$
|
1.65
|
|
5.0
|
|
$
|
|
|
The
weighted-average grant-date fair value of options granted during the nine
months ended September 30, 2007 and 2006 were $0.13 and $0.35, respectively.
Intrinsic value is defined as the difference between the relevant current
market value of the underlying common stock and the grant price for options
with exercise prices less than the market values on such dates. There were no
options exercised during the three months ended September 30, 2007 and 2006.
Options
are granted at an exercise price equal to the fair market value at the date of
grant. Information regarding stock options outstanding as of September 30, 2007
is as follows:
|
|
Options Outstanding
|
|
Options Exercisable
|
|
Range of
Exercise Price
|
|
Shares
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Life
|
|
Shares
|
|
Weighted Average Exercise Price
|
|
$0.16 - $ 1.00
|
|
3,851,168
|
|
$
|
0.41
|
|
7.9
|
|
2,309,710
|
|
$
|
0.43
|
|
$1.01 - $ 3.00
|
|
2,762,267
|
|
$
|
2.00
|
|
3.1
|
|
2,762,267
|
|
$
|
2.00
|
|
$3.01 and up
|
|
215,000
|
|
$
|
10.32
|
|
2.0
|
|
215,000
|
|
$
|
10.32
|
|
|
|
6,828,435
|
|
$
|
1.36
|
|
6.0
|
|
5,286,977
|
|
$
|
1.65
|
|
17
10.
Income Taxes
For the three months
ended September 30, 2007 and 2006, the provision for federal and state taxes
amounted to ($0.3) million and $0.5 million, respectively. For the nine months
ended September 30, 2007 and 2006, the provision for federal and state taxes
amounted to ($0.2) million and $0.5 million, respectively. During the three months
ended September 30, 2006, $0.4 million was recorded for a potential tax
liability which at the time was deemed probable. The period for review of this
tax position expired in September 2007. Since the period for review has
elapsed, the $0.4 million was reversed in the current period. The effective
income tax rate reflects the book to tax difference from goodwill amortization.
Additionally, income tax benefits from the available net operating losses are
not reflected in the 2007 and 2006 provisions as the realization of these
benefits is not deemed more likely than not.
11.
Commitments and Contingencies
The Company, from time
to time, is subject to certain asserted claims arising in the ordinary course
of business. The Company intends to vigorously assert its rights and defend
itself in any litigation that may arise from such claims. While the ultimate
outcome of these matters could affect the results of operations of any one
quarter or year when resolved in future periods, and while there can be no
assurance with respect thereto, management believes that after final
disposition, any financial impact to the Company would not be material to the
Companys financial position and results of operations or liquidity.
18
ITEM 2.
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS.
As used in
this report, the terms we, our, ours and us refer to Nextera
Enterprises, Inc, a Delaware Corporation, or Nextera, and its wholly owned subsidiaries.
In addition, the term Woodridge refers to Jocott
Enterprises, Inc., or Jocott
for all periods prior to March 9, 2006, and to Woodridge Labs, Inc., a
wholly owned subsidiary of Nextera, from and after March 9, 2006, unless the
context indicates otherwise.
Cautionary
Note Regarding Forward-Looking Statements
The following discussion
contains forward-looking statements. Forward-looking statements give our
current expectations or forecasts of future events. These statements can be identified by the fact that they do not relate
strictly to historic or current facts. They use words such as may, could,
will, continue, should, would, anticipate, estimate, expect, project,
intend, plan, believe and other words and terms of similar meaning in
connection with any discussion of future operating or financial performance. In
particular, these forward-looking statements include statements relating to
future actions or the outcome of financial results. From time to time, we also may
provide oral or written forward-looking statements in other materials released
to the public. Any or all of the forward-looking statements in this annual
report and in any other public statements may turn out to be incorrect. They
can be affected by inaccurate assumptions or by known or unknown risks and
uncertainties. Consequently, no forward-looking statement can be guaranteed.
Our actual results may differ materially from those stated or implied by such
forward-looking statements.
Factors that could cause our
actual results to differ materially include, but are not limited to:
the effects
of the voluntary recall of certain of our DermaFreeze365 products on our
business, operations and financial condition;
our ability
to repay the indebtedness and comply with the covenants under our senior
secured credit facilities;
retention of
our key personnel, particularly Mr. Millin, and our ability to attract and
retain other personnel critical to our business;
our ability
to develop and introduce new products in a highly competitive marketplace and
successfully execute market expansion plans;
the impact
of competition within our markets, and our ability to compete against companies
that are larger and more well-established than we are or that have
significantly greater resources than we do;
our reliance
on third parties for all of our product manufacturing requirements;
the loss of
any of our significant customers, as our sales are concentrated among a
relatively small number of customers;
claims
against us for infringement of intellectual property; and
other
factors
disclosed in
Nexteras Annual Report on Form 10-K for the year ended December 31, 2006 under
the heading Item 1A. Risk Factors.
New factors emerge from time
to time, and it is not possible for us to predict all these factors nor can we
assess the impact of these factors on our business or the extent to which any
factor or combination of factors may cause actual results to differ materially
from those contained in any forward-looking statements. We undertake no
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise. Given these risks and
uncertainties, you should not place undue reliance on forward-looking
statements as a prediction of actual results.
Overview
The
Managements Discussion and Analysis of Financial Condition and Results of
Operations is designed to enable the reader of our financial statements to
assess material changes in financial condition and results of operations
between the three months and nine months ended September 30, 2007 and the three
months and nine months ended September 30, 2006.
Nextera
was incorporated in the state of Delaware in 1997. On March 9, 2006,
Nextera, through W Lab Acquisition Corp., our wholly owned subsidiary, acquired
substantially all of the assets of Jocott, which formerly
19
operated under the name Woodridge
Labs, Inc. We refer to this
acquisition and all related transactions in this report as the Transaction.
Subsequently, our wholly owned subsidiary was renamed Woodridge Labs, Inc.
As used in this report, the term Woodridge refers to Jocott for all periods
prior to March 9, 2006 and to our wholly owned subsidiary Woodridge
Labs, Inc. from and after March 9, 2006. Prior to the acquisition of
the Woodridge assets, we had no business operations for the period from
November 29, 2003 through March 8, 2006. Woodridges financial
results have only been included for the period subsequent to the March 9,
2006 acquisition.
Woodridge,
our sole operating business, is an independent developer and marketer of
branded consumer products that offer simple, effective solutions to niche
personal care needs. Since its formation in 1996, Woodridge has built its
reputation and market position by identifying and exploiting underdeveloped
opportunities within the personal care market, and by commercializing
distinctive, branded products that are intended to directly address the
specific demands of niche applications. In addition to its flagship Vita-K
Solution product line, Woodridge has created a portfolio of other existing and
development-stage consumer products, covering a wide range of uses and
applications.
Our
products are marketed at retail under the following core brands: Vita-K
Solution®, DermaFreeze365,
Ellin LaVar Textures, Heavy Duty, Virtual Laser, Psssssst®, Stoppers-4®, Bath Lounge, Vita-C2, Firminol-10® and TurboShave®.
With our portfolio of products, we offer consumers affordable alternatives to
expensive dermatologist treatments, while also offering retailers profitable
and in-demand products. Our products can currently be found in over 22,000
retail locations across the United States and Canada. For the fiscal year ended
December 31, 2006, our top customers included Walgreens, CVS, and
Rite-Aid.
All
of our manufacturing, production and onsite assembly are presently outsourced
to third-parties, allowing us to focus on our core strength of discovering,
developing and marketing niche personal care products. Most of our material warehousing
and distribution functions are handled in-house and supervised by Woodridge
management.
Product Recall
On March 13, 2007,
our wholly-owned subsidiary, Woodridge, initiated a voluntary recall of certain
of its DermaFreeze365 products. This recall was a result of certain limited
lots testing positive for the
Pseudomonas
aeruginosa
bacteria. We made a provision for the recall in
our consolidated financial statements as of and for the year ended
December 31, 2006 whereby net sales and accounts receivable were reduced
by $2.3 million and inventories were written down by $0.2 million through a
charge to cost of sales. Additionally, we made an additional provision of $0.2
million during the three-month period ended March 31, 2007 for the expected customer
charge-backs related to 2007 sales of the affected products. No additional
provisions have been made for the recall during the three-month period ended
September 30, 2007.
Secured Credit Facility
In
connection with the acquisition of the Woodridge business on March 9,
2006, we entered into a senior secured credit facility, which was subsequently
amended in March 2007, April 2007 and again on November 7, 2007. We
refer to our amended senior secured credit facility in this report as the
Credit Agreement. The Credit Agreement originally consisted of a $10 million
fully-drawn term loan, of which approximately $9.5 million was outstanding at
December 31, 2006, and a four-year $5.0 million revolving credit facility,
of which approximately $2.2 million was outstanding on December 31, 2006.
Under the terms of the April 2007 amendment, the revolving credit facility
was reduced to $2.75 million. Under the terms of the November 2007
amendment, the Company obtained additional bridge loan financing of $2.5
million due no later than the final maturity of May 31, 2008. Additionally, the
financial covenants were waived for periods prior to November 7, 2007 and
modified thereafter. The maturities of the term loan and the revolving credit
facility were also accelerated to March 31, 2009. At September 30, 2007, the
revolving credit facility was fully drawn down. At September 30, 2007 the
Company failed to meet certain conditions as described under the Financing
Arrangements to the Note to Unaudited Condensed Consolidated Financial
Statements.
Heavy
Duty Acquisition
On March 8, 2007,
we entered into a purchase agreement with Heavy Duty Company and Alexandra
Volkmann, whereby we acquired certain assets, including the Heavy Duty and
other trademarks and a copyright. The total purchase price, which includes
approximately $0.1 million of deal costs, was approximately $0.3 million. We
will pay a royalty to Heavy Duty Company with respect to certain future sales
of products under the trademarks acquired from Heavy Duty Company and Alexandra
Volkmann.
20
KKG
BodyFuel Foods License Agreement
On June 21, 2007,
we entered into an Intellectual Property License Agreement with KKG BodyFuel
Foods Enterprises, Incorporated and Keri Glassman, whereby we acquired certain
rights and licenses to use various trademarks names and slogans. The
consideration consisted of a non-refundable guaranteed royalty payment of $0.1
million in the first year and minimum royalty payments of $0.1 million in each
of the next three years.
Additionally, on June
25, 2007 we entered into an Independent Contractor Agreement with KKG BodyFuel
Foods Enterprises which provides a monthly fee of $5,000 plus expenses, a stock
issuance of 200,000 shares of our Class A Common Stock and a stock option to
purchase 400,000 shares of our Class A Common Stock in exchange for promotional
services from Keri Glassman. The effective date of the agreement is July 24,
2007.
Comparison of the Three Months
Ended September 30, 2007 and 2006
Net Sales
. Sales are recorded net of
estimated returns and other allowances. The provision for sales returns
represents managements estimate of future returns based on historical
experience and considering current external factors and market conditions. Net
sales for the three months ended September 30, 2007 de
creased
$2.1 million, or 55%, to $1.7 million from $3.8 million for the same period
last year.
The net sales decrease in the current period related to a
decrease in both unit quantities shipped of 22%, and an average unit price
decrease of 23%, as well as an increase in customer credits of $0.1 million. Additionally, $1.7 million of
the decrease in net sales relates to the sales of the Virtual Laser product
line in the third quarter of 2006.
Gross Profit
.
Gross profit for the three months ended September 30, 2007 decreased $1.6
million, or 65% to $0.9 million from $2.5 million for the same period last year.
Included within gross profit for the three months ended September 30, 2006 was
a $0.1 million charge associated with the amortization of the step up to fair
value in the inventory acquired from Woodridge, as required by SFAS No. 142,
Goodwill
and Other Intangible Assets,
or
SFAS
142. Eliminating the prior year step up to fair value charge of $0.1
million, the comparative gross profit for the three-months ended September 30,
2007 decreased $1.7 million, or 66% from $2.6 million for the same period last
year. The decline in gross profit is due to the lower volume of sales of lower
margin products, increased customer credits, increased labor costs as well as
an increase in charges for inventory reserves during the three-months ended
September 30, 2007.
Selling, General and Administrative Expenses.
Selling,
general and administrative expenses for the three months ended September 30,
2007 decreased $0.5 million, or 23%, to $1.6 million from $2.1 million for the
same period last year. The decrease is due to decreased spending for selling
and advertising expense of $0.5 million, decrease in labor and facility costs
of $0.1 million related to the transfer of the corporate offices from Boston,
offset by an increase in legal and accounting professional service fees of $0.1
million.
Amortization of Intangible Assets.
Amortization
of intangible assets for the three months ended September 30, 2007 increased to
$0.3 million or, 89%, from $0.2 million for the same period last year.
Interest Expense
. Interest expense was consistent at
$0.3 million for the three months ended September 30, 2007 and for the same
period last year. The interest expense is attributable to the credit facility
that we entered into on March 9, 2006 to partially fund the Woodridge
acquisition. Our debt bears interest at the London Interbank Offered Rate or
LIBOR plus 4.50%.
Provision for Income Taxes
. For the
three months ended September 30, 2007, our benefit from federal and state taxes
amounted to $0.3 million compared to a provision of $0.5 million for the same
period in 2006. The decrease in the tax provision of $0.8 million is primarily
the result of the reversal of valuation allowances in which the period for
examination has expired. The effective income tax rate reflects the book to tax
difference from goodwill amortization. Additionally, income tax benefits from
the available net operating losses are not reflected in the 2007 and 2006
provisions as the realization of these benefits is not deemed more likely than
not.
Comparison of the Nine Months
Ended September 30, 2007 and 2006
Net Sales
. Sales are recorded net of
estimated returns and other allowances. The provision for sales returns
represents managements estimate of future returns based on historical
experience and considering current external factors and market conditions. Net
sales for the nine months ended September 30, 2007 de
creased
$1.4 million, or 16%,
21
to $7.1 million from $8.5 million
for the same period last year.
The net sales decrease in the current
period related to a decrease in both unit quantities shipped of 19%, and an
average unit price decrease of 19%, as well as an increase in customer credits
of $0.5 million or 20%. Net sales for the nine months ended September 30, 2006
reflect the operating results of the Woodridge business only from the March 9,
2006 acquisition to September 30, 2006.
The 2007
net sales include
a $0.2 million charge for expected returns related to
the March 2007 voluntary recall of certain DermaFreeze365 products sold during
the nine months ended September 30, 2007.
Gross Profit
.
Gross profit for the nine months ended September 30, 2007 decreased $0.7
million, or 15% to $4.1 million from $4.8 million for the same period last year.
Gross profit in the 2006 period only includes operating activity for the
post-Woodridge acquisition period from March 9, 2006 to September 30, 2006. The
2007 gross profit includes a $0.2 million charge for expected returns related
to the March 2007 product recall of related products sold during the nine
months ended September 30, 2007. Included within gross profit for the period
ended September 30, 2006 is a $1.4 million charge associated with the
amortization of the step up to fair value in the inventory acquired from
Woodridge, as required by SFAS 142.
Selling, General and Administrative Expenses.
Selling,
general and administrative expenses for the nine months ended September 30,
2007 and 2006 was consistent at $5.7 million. Selling, general and
administrative expenses for the nine months ending September 30, 2006 reflect
the operating results of the Woodridge business only from the March 9, 2006
acquisition to September 30, 2006. Although spending was consistent year over
year, the composition of spending changed due to lower spending for advertising
and other sales related costs of $0.9 million, offset by higher spending for
legal and accounting professional services of $0.1 million, higher spending for
labor and consulting cost of $0.3 million and higher facilities cost of $0.5
million.
Amortization of Intangible Assets.
Amortization
of intangible assets for the nine months ended September 30, 2007 increased
$0.5 million to $0.8 million from $0.3 million for the same period last year.
The increase from the 2006 relates to the full nine months amortization of the
intangible assets acquired as part of the Woodridge acquisition.
Interest Expense
. Interest expense for the nine
months ended Sept 30, 2007 increased $0.2 million, or 25% to $0.9 million from
$0.7 million for the same period last year. The interest expense is
attributable to the Credit Agreement that we entered into on March 9, 2006 to
partially fund the Woodridge acquisition. Our debt bears interest at LIBOR plus
4.50%.
Income Taxes
. For the
nine months ended September 30, 2007, our benefit from federal and state taxes
amounted to $0.2 million compared to a provision of $0.5 million for the same
period in 2006. The decrease in the tax provision of $0.7 million is primarily
the result of the release of certain unrecognized tax benefits in which the
period for examination has expired. The effective income tax rate reflects the
book to tax difference from goodwill amortization. Additionally, income tax
benefits from the available net operating losses are not reflected in the 2007
and 2006 provisions as the realization of these benefits is not deemed more
likely than not.
Liquidity and Capital Resources
Working
capital was deficit a $1.9 million on September 30, 2007, compared with a
working capital of deficit $0.8 million on December 31, 2006. Included in
working capital were cash and cash equivalents of $0.4 million and $0.6 million
on September 30, 2007 and December 31, 2006, respectively.
Net cash used in
operating activities was $4.9 million for the nine months ended September 30,
2007. Included in the net cash used in operating activities was the net loss of
$3.0 million. Non-cash operating charges including depreciation, amortization,
compensation expense and reserves were $2.4 million were offset by $4.3 million
of changes in operating assets and liabilities.
Net cash provided in investing activities
was $1.7 million for the
nine months ended September 30, 2007
,
$2.0 million relating to cash received from the Woodridge acquisition escrow
account, offset by $0.3 million relating to the purchase of the Heavy Duty
intellectual property and issuance costs.
Net cash provided in financing activities
was $3.0 million for the
nine months ended September 30, 2007
,
$2.5 million relating to cash recovered from the issuance of a note payable and
$2.7 million relating to the draw down of the credit revolver, offset by $2.2
million relating to the paydown of the revolving credit agreement.
22
Our
primary source of liquidity is our cash and cash equivalents, our cash
generated from operations, and availability under our revolving credit facility.
We
believe that our current cash on hand and sources of cash are
sufficient to meet all expenditures over the next twelve months.
The
cash generated by the operations of Woodridge and borrowed by Woodridge under
the revolving credit facility is subject to restrictions as to the amount of
funds that may be paid through a dividend to Nextera to pay corporate expenses
.
We believe that additional liquidity sources, if necessary, could be obtained
by borrowing funds from a third party or raising equity through a public or
private transaction, although these are subject to restrictions under our
Credit Agreement as amended.
On
April 17, 2007, we entered into an amendment agreement under the Credit
Agreement (the Second Amendment). Under the terms of the Second Amendment,
the revolving credit facility was reduced from $5.0 million to $2.75 million.
Pursuant to the Second Amendment, the term loan and the revolving credit
facility bear interest at the London Interbank Offered Rate (LIBOR) plus
4.50%, or bank base rate plus 3.25%, as selected by Woodridge.
On
November 7, 2007, we entered into an amendment agreement under the Credit
Agreement (the Third Amendment). Under the terms of the Third Amendment, we
obtained a bridge loan credit facility aggregating $2.5 million. Pursuant to
the Third Amendment, the bridge loan facility, the term loan and the revolving
credit facility will bear interest at the London Interbank Offered Rate (LIBOR)
plus 5.0%, or bank base rate plus 4.0%, as selected by us. Outstanding
borrowings under the bridge loan facility must be repaid with cash balances in
excess of $500,000 through the final maturity of May 31, 2008. Outstanding
borrowings under the term loan must be repaid in 4 quarterly payments,
commencing March 31, 2008, with a final payment due on March 31,
2009, the maturity date of the term loan. The maturity date for the revolving
credit facility is also March 31, 2009. The commitment fee on the
revolving credit facility is payable quarterly at a rate of 0.50% of the unused
amount of the revolving credit facility per annum. Additionally, the financial
covenants were waived for periods prior to November 7, 2007 and modified
thereafter.
We
have an interest rate collar agreement to hedge the LIBOR interest rate risk on
$5.0 million of the term loan. Under the terms of this agreement, we will pay a
6% fixed rate if the three-month LIBOR rate exceeds 6% and in return will
receive the three-month LIBOR rate. In addition, if the three-month LIBOR rate
falls below 5%, we will pay a 5% fixed rate and in return will receive the
three-month LIBOR rate. The effect of this agreement is therefore to convert
the floating three-month LIBOR rate to a fixed rate if the three-month LIBOR
rate exceeds 6% or falls below 5%. The three-month LIBOR rate received under
the agreement will substantially match the rate paid on the term loan since
term loan currently bears interest at the six-month LIBOR rate. The fair value
of the collar was ($56,000) at September 30, 2007.
Under
the Credit Agreement, as amended, we are subject to certain limitations,
including limitations on our ability: to incur additional debt or sell assets,
with restrictions on the use of proceeds; to make certain investments and
acquisitions; to grant liens; and to pay dividends and make certain other
restricted payments. In addition, we will be required to prepay principal
amounts outstanding under certain circumstances if it issues debt or equity,
sells assets or property, receives certain extraordinary receipts or generates
excess cash flow. The Credit Agreement, as amended, also contains certain
restrictive financial covenants, including minimum consolidated earnings before interest, taxes, depreciation
and amortization (EBITDA), minimum purchase order levels and maximum
corporate overhead, as defined..
Upon
the occurrence of certain events of default, our obligations under the Credit
Agreement may be accelerated and the lending commitments terminated. Such
events of default include, but are not limited to: (i) our failure to pay
principal or interest when due, (ii) our breach or failure to perform any
of the covenants or obligations set forth in the Credit Agreement, which for
certain covenants and obligations is subject to a 30-day cure period,
(iii) the acceleration of certain other indebtedness of Woodridge,
(iv) our filing of a petition in bankruptcy, (v) the entry of a
judgment or a court order against us in excess of certain specified dollar
thresholds, (vi) a reduction below certain levels in the ownership or
economic interests of our existing significant stockholders in the aggregate or
(vii) Mr. Millin ceasing to be a member of our board of directors or
the chief executive officer of Woodridge prior to March 9, 2010, except
for certain specified reasons.
Funding
Agreement and Note Conversion Agreements
On
April 16, 2007, we entered into a Funding Agreement with Woodridge, Mounte
and Jocott (the Funding Agreement). Under the terms of the Funding Agreement,
Mounte and Jocott loaned us the principal sums of $1.5 million and $1.0 million
respectively, pursuant to individual promissory notes. The notes accrued
interest at an annual rate of 7% with principal payable at the maturity date of
April 1, 2012. We were prohibited from paying interest in cash on these
notes under the terms of our Credit Agreement. Accordingly, interest was
accrued and added to the
23
principal balance of the
notes. The notes, including accrued interest, were exchanged in connection with
the Note Conversion Agreement discussed below.
The
Funding Agreement provides, subject to (i) any required consents or approvals
of the lenders under the Credit Agreement and of any other persons whose
consent or approval is required at the time under any credit or other contract
or agreement to which we, Woodridge or any of our affiliates is a party, (ii)
any required consent of the holders of the outstanding Series A Preferred, and
(iii) the approval of the Board; that, in the event that our EBITDA for a
fiscal year is greater than or equal to $7.0 million or is greater than or
equal to $12.0 million for any two consecutive fiscal years, or any event
happens that results in the exchange or redemption of, or payment of a
liquidation preference with respect to, any of our outstanding preferred stock
the Triggering Event, we will take the following actions:
a)
Within 15
business days after the occurrence of a Triggering Event, we will issue to
Jocott shares of Series B Preferred in addition to the shares of Series B
Preferred issued in connection with the Note Conversion Agreement, at a price
equal to $100 per share. The number of such additional shares to be issued to
Jocott will be equal to the quotient obtained by dividing (i) the sum of (A)
$1,000,000, plus (B) the Appreciation Amount defined below, by (ii) 100, and
rounding down to the nearest whole share. Such shares of Series B Preferred
will be issued to Jocott in consideration of Jocotts irrevocable payment of
the $2.0 million indemnity deposit and Jocotts compromise and settlement of
the past, pending and future specified claims. The Appreciation Amount means
an amount equal to a deemed appreciation equal to (1) $1,000,000, multiplied by
(2) seven percent (7%) per annum, compounded annually, calculated from the date
that Jocott loaned the funds to us pursuant to the promissory note issued by
Jocott until the date of the any issuance of the additional shares of Series B
Preferred to Jocott.
b)
Within 15
business days after the occurrence of a Triggering Event, we will also issue to
Jocott the same number of shares of our Series C Cumulative Non-Convertible
Preferred Stock or Series C Preferred, as the number of additional shares of
Series B Preferred issued to Jocott. The Series C Preferred will (i) be issued
at a price equal to $100 per share, (ii) have a liquidation preference equal to
$100 per share and (iii) provide for a 7% paid-in-kind dividend. The Series C
Preferred will not be convertible into any other securities of ours and the
Series C Preferred will rank (i) junior to the Series A Preferred as to the
payment of dividends and as to the distribution of assets upon liquidation,
dissolution or winding up, and (ii) on a parity with the Series B Preferred as
to the payment of dividends and the Special Redemption Right noted below, but
rank junior to the Series B Preferred as to the distribution of assets upon
liquidation, dissolution or winding up. The Series C Preferred will be
structured so as to comply with any applicable restrictions in any credit or
other contract or agreement to which we, Woodridge or any of our affiliates is
a party. Such shares of Series C Preferred will be issued to Jocott in
consideration of Jocotts irrevocable payment of the $2.0 million indemnity
deposit and Jocotts compromise and settlement of the past, pending and future
specified claims.
c)
We will
grant to the holders of Series A Preferred, Series B Preferred and Series C
Preferred the right or the Special Redemption Right, the exercise of which is
conditioned upon the occurrence of a Triggering Event, the request of the
holders and the approval of our board of directors, to redeem all or a portion of the shares of
the Preferred Stock held by such holders at a redemption price equal to $100
per share (plus any applicable accrued but unpaid dividends on the shares so
redeemed). The Special Redemption Right of the holders of Series A Preferred
will be senior and prior to the Special Redemption Rights of the holders of
Series B Preferred and Series C Preferred, and the Special Redemption Rights of
the holders of Series B Preferred and Series C Preferred will be on a parity
with each other.
Additionally,
under the provisions of the Funding Agreement, in connection with and at the
time of the issuance of any Series B Preferred and/or Series C
Preferred, we will issue warrants to purchase our Class A Common Stock at
an exercise price of $0.50 per share (the Warrants) to the holder of such
Series B Preferred and/or Series C Preferred. The number of shares of
our Class A Common Stock for which such warrants will be exercisable will
be equal to (i) with respect to notes redeemed or exchanged for
Series B Preferred , the product of (A) the outstanding principal
balance plus all accrued but unpaid interest that was redeemed or exchanged,
multiplied by (B) two (2); (ii) 2,000,000 shares with respect to the
Series B Preferred Stock issued upon the occurrence of a Triggering Event
(when and if such Series B Preferred is issued), and (iii) 2,000,000
shares with respect to the Series C Preferred issued upon the occurrence
of a Triggering Event (when and if such Series C Preferred is issued). The
Warrants will have a ten (10) year term and have customary piggyback
registration rights and anti-dilution rights and other rights with respect to
specified events, all as determined by our board of directors.
On
June 15, 2007, we entered into a Note Conversion Agreement whereby we
exchanged all outstanding principal and accrued interest owed to Mounte and
Jocott pursuant to individual promissory notes executed in connection with the
Funding Agreement for 15,169 and 10,113 shares, respectively, of Nexteras
Series B Preferred, together with a cash payment in lieu of fractional shares.
The Series B Preferred was issued at a price of $100 per share, has a
24
liquidation preference
of $100 per share, provides for a 7% per annum cumulative paid-in-kind
dividend, and entitles its holders to a number of votes equal to the number of
shares held. The Series B Preferred is not convertible into any of our
other securities and ranks junior to the Series A Preferred Stock as to
the payment of dividends, the issuance of a special redemption, and the
distribution of assets upon liquidation, dissolution or winding up. The
Series B Preferred is structured so as to qualify as Permitted Equity
Interests as such term is defined in our Credit Agreement, as amended.
In connection with the
issuance of Series B Preferred, we also issued a Class A Common Stock
Purchase Warrant to each of Mounte and Jocott, pursuant to the terms of a
Funding Agreement. Under such Warrants, we granted Mounte and Jocott the right
to purchase 3,033,945 and 2,022,630 shares, respectively, of our Class A
Common Stock at an exercise price of $0.50 per share, exercisable at any time
at the option of the holder. The Warrants have a ten- (10) year term and have customary piggyback
registration rights and anti-dilution rights with respect to specified events.
The fair value of the warrants has been determined to be $647,000. This amount
was calculated using the Black-Scholes pricing model with the following
assumptions: 118.9% volatility; expected term of 10 years; 5.10% risk-free
rate; and 0% dividend.
The Series B Preferred is
classified as mezzanine equity as the Special Redemption Right is effectively
redeemable at the option of the holder and ais not solely within the control of
the issuer. The initial carrying amount of the Series B Preferred is the fair
value at issuance. The Series B Preferred will not be accreted to the
redemption value of $2.5 million until redemption is considered probable. The
7% paid-in-kind dividend accrues to the carrying value of the Series B
Preferred.
Certain
Contractual Obligations, Commitments and Contingencies
The following summarizes
our significant contractual obligations and commitments at September 30, 2007
that impact our liquidity.
|
|
Payments due by Period
|
|
Contractual Obligations
(in thousands)
|
|
Total
|
|
Less than 1
year
|
|
1-3 years
|
|
4-5 years
|
|
After 5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
$
|
9,500
|
|
$
|
750
|
|
$
|
8,750
|
|
$
|
|
|
$
|
|
|
Leases
|
|
1,702
|
|
445
|
|
862
|
|
395
|
|
|
|
Total
|
|
$
|
11,202
|
|
$
|
1,195
|
|
$
|
9,612
|
|
$
|
395
|
|
$
|
|
|
Off
Balance Sheet Arrangements
We have not entered into
any off-balance sheet transactions, arrangements or obligations (including
contingent obligations) that have, or are reasonably likely to have, a material
effect on our financial condition, changes in financial condition, revenues or
expenses, results of operations, liquidity, capital expenditures or capital
resources.
Critical
Accounting Policies
Our discussion and
analysis of our financial condition and results of operations are based upon
our condensed consolidated financial statements, which have been prepared in
accordance with accounting principles generally accepted in the United States.
The preparation of these financial statements requires us to make estimates and
judgments that affect the reported amounts of assets, liabilities, revenues and
expenses, and related disclosures of contingent assets and liabilities.
We believe the
accounting policies below represent our critical accounting policies. See our
Annual Report on Form 10-K for the year ended December 31, 2006 for a detailed
discussion on the application of these and other accounting policies.
Revenue Recognition,
Allowances for Sales Returns
and Markdowns
We
recognize sales when title and risk of loss transfer to the customer, the sales
price is fixed or determinable and collection of the resulting receivable is
probable. Sales are recorded net of estimated returns and other allowances. Our
provision for sales returns represents managements estimate of future returns
based on historical experience and considering current external factors and
market conditions.
25
Our sales-return accrual
is a subjective critical estimate that has a direct impact on reported net
sales. As is customary in the industry, we grant certain of our
customers, subject to authorization and approval, the right to either return
products or to receive a markdown allowance for certain promotional product.
Upon sale, we record a provision for product returns and markdowns estimated
based on our historical and projected experience, economic trends and changes
in customer demand. There is considerable judgment used in evaluating the
factors influencing the allowance for returns and markdowns, and therefore
additional allowances in any particular period may be needed. The types of
known or anticipated events that we have considered, and will continue to
consider, include, but are not limited to, the solvency of our customers, store
closings by retailers, changes in the retail environment, including mergers and
acquisitions, and our decision to continue or support new and existing
products. Actual sales returns and markdowns may differ significantly, either
favorably or unfavorably, from these estimates.
Provisions for Inventory Obsolescence
We record a provision for estimated obsolescence of
inventory. These estimates consider the cost of inventory, forecasted demand,
the estimated market value, the shelf life of the inventory and historical
experience. If there are changes to these estimates, additional provisions for
inventory obsolescence may be necessary.
Accounting for Acquisitions and Intangible Assets
We have
accounted for our acquisitions under the purchase method of accounting for
business combinations. Under the purchase method of accounting, the costs,
including transaction costs, are allocated to the underlying net assets, based
on their respective estimated fair values. The excess of the purchase price
over the estimated fair values of the net assets acquired is recorded as
goodwill.
Our judgments made in determining
the estimated fair value and expected useful lives assigned to each class of
assets and liabilities acquired can significantly affect net income. For
example, different classes of assets will have useful lives that differ and the
useful life of property, plant, and equipment acquired will differ
substantially from the useful life of brand licenses and trademarks.
Consequently, to the extent a longer-lived asset is ascribed greater value
under the purchase method than a shorter-lived asset, net income in a given
period may be higher.
Determining
the fair value of certain assets and liabilities acquired is judgmental in
nature and often involves the use of significant estimates and assumptions. One
of the areas that requires more judgment is determining the fair value and
useful lives of intangible assets. To assist in this process, we often obtain
appraisals from independent valuation firms for certain intangible assets.
Our
intangible assets primarily consist of customer relationships, non-compete
covenants, exclusive brand licenses and trademarks. The value of the intangible
assets, including customer relationships and other intangibles, is exposed to
future adverse changes if we experience declines in operating results or
experience significant negative industry or economic trends. We periodically
review intangible assets, at least annually or more often as circumstances
dictate, for impairment and the useful life assigned using the guidance of
applicable accounting literature.
Long-Lived Assets
We review for the impairment of long-lived assets to be held
and used whenever events or changes in circumstances indicate that the carrying
amount of such assets may not be fully recoverable. Measurement of an
impairment loss is based on the fair value of the asset compared to its
carrying value. Long-lived assets to be disposed of are reported at the lower
of carrying amount or fair value less costs to sell.
ITEM 3.
QUANTITATIVE AND QUALITATIVE
DISCLOSURES ABOUT MARKET RISK.
Interest
Rate Risk
As of September 30, 2007,
we had $9.5 million in floating rate debt under the term loan of our
Credit Agreement. Changes in interest rates would not significantly affect the
fair value of our outstanding indebtedness. Our term loan currently bears interest
at the six-month LIBOR rate plus 4.50%. Our revolving credit facility bears
interest at different rates, ranging from one-month and three-month LIBOR plus
4.50% to base rate plus 3.25%. We have an interest rate collar agreement
pertaining to $5.0 million of our term loan with respect to the
three-month LIBOR rate, which effectively caps the rate at 6% and provides for
a 5% floor. Assuming the outstanding balance on our floating rate indebtedness
remains constant over a year, a 100 basis point increase in the interest rate
would decrease pre-tax income and cash flow by approximately
$0.12 million.
26
Foreign
Currency Risk
We are not currently
exposed to foreign currency risk because we do not currently have material
business operations in foreign countries or any related sales and expenses
ITEM 4. CONTROLS
AND PROCEDURES.
We maintain disclosure
controls and procedures that are designed to ensure that information required
to be disclosed in our reports under the Securities Exchange Act of 1934, as
amended, and the rules and regulations thereunder, is recorded, processed,
summarized and reported within the time periods specified in the Securities and
Exchange Commissions rules and forms and that such information is accumulated
and communicated to management, including our President and Chief Financial
Officer, as appropriate, to allow for timely decisions regarding required
disclosure. In designing and evaluating the disclosure controls and procedures,
management recognizes that any controls and procedures, no matter how well
designed and operated, can provide only reasonable assurance of achieving the
desired control objectives, and management is required to apply its judgment in
evaluating the cost-benefit relationship of possible controls and procedures.
As required by SEC
Rule 13a-15(b), we carried out an evaluation, under the supervision and
with the participation of our management, including our President and Chief
Financial Officer, of the effectiveness of the design and operation of our
disclosure controls and procedures as of the end of the period covered by this
report. Based on the foregoing, our President and Chief Financial Officer
concluded that our disclosure controls and procedures were effective at the
reasonable assurance level as of September 30, 2007.
There have been no
changes in our internal controls over financial reporting during our most
recent fiscal quarter that have materially affected, or are reasonably likely
to materially affect, our internal controls over financial reporting
.
27